"Danazol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
| Descriptor ID |
D003613
|
| MeSH Number(s) |
D04.210.500.745.432.235
|
| Concept/Terms |
Danocrine- Danocrine
- Ladogal
- Cyclomen
- Danatrol
- Danol
|
Below are MeSH descriptors whose meaning is more general than "Danazol".
Below are MeSH descriptors whose meaning is more specific than "Danazol".
This graph shows the total number of publications written about "Danazol" by people in this website by year, and whether "Danazol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Danazol" by people in Profiles.
-
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks During COVID-19. J Investig Allergol Clin Immunol. 2021 Jul 26; 31(4):356-357.
-
Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices. J Heart Lung Transplant. 2020 05; 39(5):498-500.
-
Clinical Features of Hereditary Angioedema in Korean Patients: A Nationwide Multicenter Study. Int Arch Allergy Immunol. 2018; 176(3-4):272-279.
-
Danazol increases T regulatory cells in patients with aplastic anemia. Hematology. 2018 Sep; 23(8):496-500.